BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tsianos EV, Katsanos KH, Tsianos VE. Role of genetics in the diagnosis and prognosis of Crohn's disease. World J Gastroenterol 2012; 18(2): 105-118 [PMID: 22253516 DOI: 10.3748/wjg.v18.i2.105] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Abbass M, Cepek J, Parker CE, Nguyen TM, MacDonald JK, Feagan BG, Khanna R, Jairath V. Adalimumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2019;2019. [PMID: 31742665 DOI: 10.1002/14651858.CD012878.pub2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
2 Coskun M, Bjerrum JT, Seidelin JB, Nielsen OH. MicroRNAs in inflammatory bowel disease - pathogenesis, diagnostics and therapeutics. World J Gastroenterol 2012; 18(34): 4629-4634 [PMID: 23002331 DOI: 10.3748/wjg.v18.i34.4629] [Cited by in CrossRef: 63] [Cited by in F6Publishing: 62] [Article Influence: 6.3] [Reference Citation Analysis]
3 Shaghaghi Z, Bonyadi M, Somi MH, Khoshbaten M. Association of plasminogen activator inhibitor-1 gene polymorphism with inflammatory bowel disease in Iranian Azeri Turkish patients. Saudi J Gastroenterol 2014;20:54-8. [PMID: 24496159 DOI: 10.4103/1319-3767.126322] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
4 Leal RF, Milanski M, Coy CSR, Portovedo M, Rodrigues VS, Coope A, Ayrizono MDLS, Fagundes JJ, Velloso LA. Autophagy and proinflammatory cytokine expression in the intestinal mucosa and mesenteric fat tissue of patients with Crohn's disease. Journal of Coloproctology 2021;33:009-15. [DOI: 10.1016/j.jcol.2012.10.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Romero-Cara P, Torres-Moreno D, Pedregosa J, Vílchez JA, García-Simón MS, Ruiz-Merino G, Morán-Sanchez S, Conesa-Zamora P. A FCGR3A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF. Int J Med Sci 2018;15:10-5. [PMID: 29333082 DOI: 10.7150/ijms.22812] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
6 Lacruz-Guzmán D, Torres-Moreno D, Pedrero F, Romero-Cara P, García-Tercero I, Trujillo-Santos J, Conesa-Zamora P. Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn’s disease and ulcerative colitis. Eur J Clin Pharmacol. 2013;69:431-438. [PMID: 22960943 DOI: 10.1007/s00228-012-1389-0] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
7 Alawi F. An update on granulomatous diseases of the oral tissues. Dent Clin North Am 2013;57:657-71. [PMID: 24034071 DOI: 10.1016/j.cden.2013.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
8 Alamdari-Palangi V, Vahedi F, Shabaninejad Z, Dokeneheifard S, Movehedpour A, Taheri-Anganeh M, Savardashtaki A. microRNA in inflammatory bowel disease at a glance. Eur J Gastroenterol Hepatol 2021;32:140-8. [PMID: 32558695 DOI: 10.1097/MEG.0000000000001815] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lichtenstein GR, Loftus EV, Isaacs KL, Regueiro MD, Gerson LB, Sands BE. ACG Clinical Guideline: Management of Crohn's Disease in Adults. Am J Gastroenterol. 2018;113:481-517. [PMID: 29610508 DOI: 10.1038/ajg.2018.27] [Cited by in Crossref: 390] [Cited by in F6Publishing: 311] [Article Influence: 97.5] [Reference Citation Analysis]
10 Alenazi N, Alsaeed H, Alsulami A, Alanzi T. A Review of Hyperbaric Oxygen Therapy for Inflammatory Bowel Disease. Int J Gen Med 2021;14:7099-105. [PMID: 34729019 DOI: 10.2147/IJGM.S336678] [Reference Citation Analysis]
11 Kahraman AS. Editorial for "Novel Associations Between Genome-Wide Single Nucleotide Polymorphisms and MR Enterograpy Features in Crohn's Disease Patients". J Magn Reson Imaging 2021;53:139-40. [PMID: 32896076 DOI: 10.1002/jmri.27356] [Reference Citation Analysis]
12 Salem M, Seidelin JB, Rogler G, Nielsen OH. Muramyl dipeptide responsive pathways in Crohn’s disease: from NOD2 and beyond. Cell Mol Life Sci 2013;70:3391-404. [DOI: 10.1007/s00018-012-1246-4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
13 Moon JS. Clinical Aspects and Treatments for Pediatric Inflammatory Bowel Diseases. Pediatr Gastroenterol Hepatol Nutr. 2019;22:50-56. [PMID: 30671373 DOI: 10.5223/pghn.2019.22.1.50] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
14 Igaz I, Szőnyi M, Varga P, Topa L. [Potential relevance of microRNAs in the diagnostics of inflammatory bowel diseases]. Orv Hetil 2014;155:487-91. [PMID: 24659741 DOI: 10.1556/OH.2014.29864] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
15 Jiang T, Qin B, He J, Lin S, Ding S. Three isoforms of the Atg16L1 protein contribute different autophagic properties. Mol Cell Biochem 2013;378:257-66. [PMID: 23512522 DOI: 10.1007/s11010-013-1616-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
16 Fung I, Garrett JP, Shahane A, Kwan M. Do bugs control our fate? The influence of the microbiome on autoimmunity. Curr Allergy Asthma Rep 2012;12:511-9. [PMID: 22886439 DOI: 10.1007/s11882-012-0291-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
17 Carcano C, Oliveira EC, Martinez F, Kirsch J. Endobronchial carcinoid tumor in a Crohn disease patient treated with a TNFα inhibitor. Transl Lung Cancer Res 2013;2:E29-32. [PMID: 25806214 DOI: 10.3978/j.issn.2218-6751.2012.12.03] [Reference Citation Analysis]
18 Kumar M, Hemalatha R, Nagpal R, Singh B, Parasannanavar D, Verma V, Kumar A, Marotta F, Catanzaro R, Cuffari B, Jain S, Bissi L, Yadav H. PROBIOTIC APPROACHES FOR TARGETING INFLAMMATORY BOWEL DISEASE: AN UPDATE ON ADVANCES AND OPPORTUNITIES IN MANAGING THE DISEASE. Int J Probiotics Prebiotics 2016;11:99-116. [PMID: 31452650] [Reference Citation Analysis]
19 Bianco AM, Zanin V, Monasta L, Martelossi S, Marcuzzi A, Crovella S. Family history in early-onset inflammatory bowel disease. J Gastroenterol 2013;48:144. [PMID: 22886482 DOI: 10.1007/s00535-012-0654-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Bhullar M, Macrae F, Brown G, Smith M, Sharpe K. Prediction of Crohn’s disease aggression through NOD2/CARD15 gene sequencing in an Australian cohort. World J Gastroenterol 2014; 20(17): 5008-5016 [PMID: 24803813 DOI: 10.3748/wjg.v20.i17.5008] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
21 Zhang J, Wu J, Peng X, Song J, Wang J, Dong W. Associations between STAT3 rs744166 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis. PLoS One. 2014;9:e109625. [PMID: 25286337 DOI: 10.1371/journal.pone.0109625] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.4] [Reference Citation Analysis]
22 Spalinger MR, Lang S, Weber A, Frei P, Fried M, Rogler G, Scharl M. Loss of protein tyrosine phosphatase nonreceptor type 22 regulates interferon-γ-induced signaling in human monocytes. Gastroenterology. 2013;144:978-988.e10. [PMID: 23380085 DOI: 10.1053/j.gastro.2013.01.048] [Cited by in Crossref: 29] [Cited by in F6Publishing: 36] [Article Influence: 3.2] [Reference Citation Analysis]
23 Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 2013;26:822-80. [PMID: 24092857 DOI: 10.1128/CMR.00022-13] [Cited by in Crossref: 644] [Cited by in F6Publishing: 333] [Article Influence: 80.5] [Reference Citation Analysis]
24 Bonyadi MJ, Gerami SM, Somi MH, Khoshbaten M. Effect of the C3435T polymorphism of the multidrug resistance 1 gene on the severity of inflammatory bowel disease in Iranian Azeri Turks. Saudi J Gastroenterol. 2013;19:172-176. [PMID: 23828747 DOI: 10.4103/1319-3767.114515] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
25 Li YW, Yang CQ, Xiao YL, Li J, Xie CX, Zhang SH, Yu Q, Wang HL, Lu WM, Chen MH. The -A2518G polymorphism in the MCP-1 gene and inflammatory bowel disease risk: A meta-analysis. J Dig Dis. 2015;16:177-185. [PMID: 25620350 DOI: 10.1111/1751-2980.12232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
26 Zhang JX, Song J, Wang J, Dong WG. JAK2 rs10758669 polymorphisms and susceptibility to ulcerative colitis and Crohn's disease: a meta-analysis. Inflammation. 2014;37:793-800. [PMID: 24385239 DOI: 10.1007/s10753-013-9798-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
27 Momotani E, Ozaki H, Hori M, Yamamoto S, Kuribayashi T, Eda S, Ikegami M. Mycobacterium avium subsp. paratuberculosis lipophilic antigen causes Crohn's disease-type necrotizing colitis in Mice. Springerplus 2012;1:47. [PMID: 23519342 DOI: 10.1186/2193-1801-1-47] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
28 Wang X, Qin L, Cao J, Zhao J. Impact of NOD2/CARD15 polymorphisms on response to monoclonal antibody therapy in Crohn's disease: a systematic review and meta-analysis. Curr Med Res Opin 2016;32:2007-12. [PMID: 27533749 DOI: 10.1080/03007995.2016.1226168] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
29 Nelson SM, Nguyen TM, McDonald JW, MacDonald JK. Natalizumab for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2018;8:CD006097. [PMID: 30068022 DOI: 10.1002/14651858.CD006097.pub3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
30 Gonçalves P, Magro F, Martel F. Metabolic inflammation in inflammatory bowel disease: crosstalk between adipose tissue and bowel. Inflamm Bowel Dis 2015;21:453-67. [PMID: 25248003 DOI: 10.1097/MIB.0000000000000209] [Cited by in Crossref: 43] [Cited by in F6Publishing: 18] [Article Influence: 6.1] [Reference Citation Analysis]
31 Scolaro BL, Santos ED, Ferreira LE, França PHCD, Kleinubing H, Kotze PG, Pinho MDSL. T300A GENETIC POLYMORPHISM: a susceptibility factor for Crohn’s disease? Arq Gastroenterol 2014;51:97-101. [DOI: 10.1590/s0004-28032014000200005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
32 Cruz‐romero C, Guo A, Bradley WF, Vicentini JR, Yajnik V, Gee MS. Novel Associations Between Genome‐Wide Single Nucleotide Polymorphisms and MR Enterography Features in Crohn's Disease Patients. J Magn Reson Imaging 2021;53:132-8. [DOI: 10.1002/jmri.27250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 Moon JS. Clinical aspects and treatments for pediatric inflammatory bowel disease. Intest Res 2019;17:17-23. [PMID: 30625263 DOI: 10.5217/ir.2018.00139] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
34 Dragasevic S, Stankovic B, Milosavljevic T, Sokic-Milutinovic A, Lukic S, Alempijevic T, Zukic B, Kotur N, Nikcevic G, Pavlovic S, Popovic D. Genetic and environmental factors significant for the presentation and development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2017;29:909-15. [PMID: 28452812 DOI: 10.1097/MEG.0000000000000877] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Shen Y, Guo S, Yang T, Jia L, Chen L, An J, Wang T, Wen F. The -173 G/C polymorphism of the MIF gene and inflammatory bowel disease risk: a meta-analysis. Int J Mol Sci 2013;14:11392-401. [PMID: 23759989 DOI: 10.3390/ijms140611392] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]